Torrent Pharmaceuticals Limited has informed the Exchange about Credit Rating
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ICRA Limited has reaffirmed Torrent Pharmaceuticals' long-term credit rating for its banking facilities and Non-Convertible Debentures at AA+ with a Stable outlook. ICRA also reaffirmed the rating for the existing amount of the company's commercial paper programme at A1+ and assigned the same rating for an enhanced (increased) amount. AA+ (Stable) is a high investment-grade rating, and A1+ is the highest short-term rating, indicating strong financial health and low default risk.
No negative impact on shareholders; the reaffirmation signals that the company's creditworthiness remains strong and stable. The enhancement of the commercial paper programme suggests improved access to short-term funding at favorable rates.